Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on March 6, 2019. The filing serves as a Regulation FD disclosure regarding an upcoming Investor Conference scheduled for March 7, 2019, in New York, New York.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on the announcement of an event rather than the reporting of financial results.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document references the reaffirmation of previously issued guidance rather than new financial data.
Guidance, Outlook, and Risks
Guidance and Outlook
Company officers intend to reaffirm all full-year 2019 guidance metrics that were originally issued in the fourth quarter and full-year 2018 earnings release. No new guidance figures are provided in this text.
Risks and Contingencies
The filing includes a comprehensive list of forward-looking statement risks, including:
- Regulatory changes to the Affordable Care Act (ACA) and legal challenges thereto.
- Trends in healthcare costs, utilization rates, and premium rate approvals.
- Competitive pressures and reduced enrollment.
- Data security breaches and unauthorized disclosure of sensitive information.
- Risks related to Medicare and Medicaid programs, including CMS Star ratings.
- Litigation with Cigna Corporation regarding the terminated merger agreement, including potential termination fees and damages.
- Pharmacy benefit management transition risks involving Express Scripts and CVS Health.
- Substantial outstanding indebtedness and potential credit rating downgrades.
- Impairment of goodwill and intangible assets.
Investor Verification Checklist
- Verify the specific full-year 2019 guidance metrics in the Q4 2018 earnings release referenced by management.
- Review the status of the litigation between Anthem and Cigna Corporation regarding the merger termination.
- Monitor regulatory developments concerning the ACA and state-level healthcare regulations.
- Assess the progress of the pharmacy benefit management transition from Express Scripts to CVS Health.
- Check for any updates on data security investigations or member information breaches.